genome Archives - NFCR

genome

NFCR’s Genomics Newsroom: Using Molecular Imaging to Guide Cancer Therapy

Molecular imaging combines conventional anatomic imaging with genomic testing and enables doctors to literally see cancer at its molecular or genetic level....

Read more

2017: The Year of Cancer Genomics

National Foundation for Cancer Research CEO Franklin Salisbury Jr. predicts: "It looks like 21st century medicine will be about cancer genomics."...

Read more

NFCR’s Genomics Newsroom: Bladder Cancer Could Be Treated the Same Way as Breast Cancer

Researchers from UNC, Chapel Hill found a subtype of bladder cancer has the same molecular signatures as a subset of breast cancer....

Read more

NFCR’s Genomics Newsroom: Discovery of New Lung Cancer Mutation

The U.S. FDA approved the first and only drug to treat people with advanced non-small cell lung cancer (NSCLC) whose tumors express the ROS1+ mutation....

Read more

National Foundation for Cancer Research and KEW, Inc. announce a collaboration

National Foundation for Cancer Research and KEW, Inc. announce a collaboration to increase awareness of the value of genetic testing. Big Data comes to Cancer Care Choices.  #Research4aCure BETHESDA, Maryland (June 8, 2016)  – The National Foundation for Cancer Research (NFCR) and Kew, Inc, a private oncology services company based…...

Read more

WE ARE THE HERETICS: Sequence that cancer!

WE ARE THE HERETICS:  Sequence that cancer! Heretic: someone who believes or teaches something that goes against accepted or official beliefs        http://www.merriam-webster.com/dictionary/heretic Here’s an important question: Did your friend’s oncologists sequence their cancer? You’ve heard a lot about targeted cancer therapies recently.  This is all about molecular profiling, i.e., identifying…...

Read more